Monday 08 August 2022
WINMED shows results for the second quarter of 2022 with a profit of 292%, with a total revenue of 191.66 million baht. Products-services of the Covid-19 screening group drive sales More users of health check-up services in hospitals Supporting women’s health care products Expect the direction of the second half of the year to grow continuously Get business high season Prepare to launch a new product, a self-test for cervical cancer and sexually transmitted diseases Accelerate the development of distribution channels Expanding the service of a mobile blood donation center Get more demand Generate total income, grow according to the goals set.
Mr. Nantiya Darkanon, Chief Executive Officer of Winnergy Medical Public Company Limited or WINMED, an importer and distributor of tools and a set of equipment for storage Medical examination, diagnosis and treatment Revealed that the results of the 2Q22 quarter, the company had a total revenue of 191.66 million baht, an increase from the same period of the previous year with a total revenue of 116.36 million baht or 65% and a net profit of 15.31 million baht, an increase from the same period. Last year with a net profit of 3.91 million baht, or an increase of 292%.
As for the results of the first half of 2022, the company has total revenue of 347.93 million baht, an increase from the same period last year with a total revenue of 235.32 million baht, amounting to 112.61 million baht, or an increase of 48% and a net profit of 27.89 million baht, an increase. From the same period last year with a net profit of 14.47 million baht, amounting to 13.42 million baht, or an increase of 93%.
However, 2Q22 results in revenue and profit have improved. This was attributed to the increase in sales of COVID-19 Rapid Test Kits (ATK) and revenue from real-time RT-PCR (RT-PCR) genomic testing standards laboratories due to the epidemic. In addition, the government has announced the relaxation of preventive measures and control of the spread of COVID-19 in 2Q22, people are confident in using more health check-up services, resulting in revenue from sales. Cervical cancer screening kit products for the NHSO project (National Health Security Office) and hospital customers increased. Driving revenue for women’s health products to grow steadily
For the business direction in the second half of year 65 It is expected to have an outstanding growth trend. Because it is the high season of the business, prepare to launch new products. Cervical cancer and STDs Self-Collect (HPV & STDs Self-Collect) kit for women and men under the product name “AVA”, which can be delivered for HPV mRNA analysis at the clinic. WINMED medical techniques, results are known within 5-7 days. Currently in the process of publicizing the knowledge of the product and accelerating the development of distribution channels both online and offline through various distribution channels such as pharmacies, organizing agents. sell in order to be able to reach the target customers covering the whole country which is expected to launch products and services in August 65
In addition, the blood banking business – blood safety After serving at the mobile blood donation center at Rajavithi Hospital and Phra Pinklao Hospital received a good response Prepare plans to expand additional network units. Support for higher blood demand
However, the company is committed to developing and supplying more innovative medical products continuously. to be in line with the situation in the country Meet and support the health needs of B2B and B2C customers as a supporting factor to drive the company’s total revenue. grow according to the goals set